Health
globalreutersOctober 24, 20241 Mins read
Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’
globalreutersOctober 24, 20241 Mins read 
Radiant Biotherapeutics’ Multabodies are antibodies engineered to offer better binding strength to their targets. The preclinical startup’s lead program goes after a cancer immunotherapy target being pursued by several biotech companies already in early clinical development.
The post Gates Foundation Joins Radiant Bio’s $35M Round for Antibody Drugs With ‘Better Grip’ appeared first on MedCity News.
Related Articles
Heat-related illnesses are preventable; here’s how
By PHIYEN NGUYEN & KRISTINA CARVALHO As we enjoy the crisp air...
WTW: There’s A Disconnect Between Employers and Employees on Wellbeing Programs
Employers are prioritizing mental wellbeing programs, but employees say they need financial...
Best hospital for Congenital Hip Dislocation Treatment
Developmental dysplasia of the hip, also known as congenital hip dislocation, is...
A Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal Hemoglobinuria
That is the title of my recent paper with co-authors Denise Clayton,...
Leave a comment